This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
ReportsnReports.com adds new market research report “Infectives Vaccine Partnering Terms and Agreements” to its store.
Dallas, Texas (PRWEB) November 25, 2012
This report provides a detailed understanding and analysis of how and why companies enter infectives vaccine partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors vaccine technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. The report also includes adjuvant deals and alliances.
This report provides details of the latest infectives vaccine agreements announced in the healthcare sectors.
This report contains a comprehensive listing of all infectives vaccine partnering deals announced since January 2007, including financial terms where available, including over 300 links to online deal records of actual vaccine partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners.
Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.
The initial chapters of this report provide an orientation of infectives vaccine dealmaking and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in infectives vaccine dealmaking since 2007, including details of average headline, upfront, milestone and royalty terms.
Chapter 3 provides a review of the leading infectives vaccine deals since 2007. Deals are listed by headline value, signed by bigpharma, most active bigpharma, and most active of all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.
Chapter 4 provides a comprehensive and detailed review of infectives vaccine partnering deals signed and announced since January 2007, where a contract document is available in the public domain. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and specific therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Infectives Vaccine Partnering Agreements is intended to provide the reader with an in-depth understanding and access to infectives vaccine trends and structure of deals entered into by leading companies worldwide.
Infectives Vaccine Partnering Agreements includes:
In Infectives Vaccine Partnering Agreements, the available deals are listed by:
The Infectives Vaccine Partnering Agreements report provides comprehensive access to available deals and contract documents for over 600 infectives vaccine deals.
Dermatology Partnering Terms and Agreementsprovides the reader with the following key benefits:
Dermatology Partnering Terms and Agreements is intended to provide the reader with an in-depth understanding and access to dermatology trends and structure of deals entered into by leading companies worldwide.
Dermatology Partnering Terms and Agreements includes:
In Dermatology Partnering Terms and Agreements, available deals and contracts are listed by:
Buy your copy of report @ http://www.reportsnreports.com/reports/204158-infectives-vaccine-partnering-terms-and-agreements.html
Browse more reports on Pharmaceutical Market @ http://www.reportsnreports.com/market-research/pharmaceuticals/
Contact firstname.lastname@example.org for further information.
ReportsnReports.com is an online market research reports library of 200,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers.
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebinfectives-vaccine/partnering-agreements/prweb10164682.htm